Trial intelligence / Profile preview

Enarodustat observational study in heart failure patients with renal anemia

jRCT1041240013Completed

Sponsor
N/A
Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of enarodustat and Iron in anemia of renal disease and heart failure (HF), sponsored by N/A. Started Apr 2024; status: completed.

02

Drugs

enarodustatIron
03

Conditions

anemia of renal diseaseheart failure (HF)

Beyond the preview

Go deeper on jRCT1041240013.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1041240013.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call